Colgate Palmolive (CL)

A great company, but has a high multiple, at the high end of these consumer type companies. Prefers PG-N, who are making some changes and getting rid of some products and buying back some of their shares. These companies need to re-think their product line and rationalize it. CL-N is a well run company, but you pay a higher multiple.

Consumer stocks have done really, really well. This stock has been subject to takeover speculation. This type of company is viewed as likely consolidation partners in a very, very low inflationary environment. They are good, solid, well run companies with tremendous marketing teams behind them. The big theory was always that the next big growth was going to be in emerging markets. To some extent, we have seen that in this company. As these markets develop, we are starting to see new competitive entrants from the countries themselves. You are already in a low margin product where you are trying to push as much volume out the door as you possibly can. Well-run company, but not a lot of pricing power anymore.

This is one of those pretty stable consumer stocks so you can always feel safe on it. The only question he would have on this is what is going to happen to the US currency so he has tended to avoid a lot of the US stocks. This is one that will continue to grow its dividend because the profits are pretty well global. 2.3% yield.

Has done phenomenal. Increase dividend regularly. Always expensive and hard to buy on a dip. You should be fine. 2.25% dividend yield. Fully valued but they will regularly increase the dividend.

This stock has performed very well. Mainly in oral care and pet care. Have a lot of emerging-market exposure. Given how well the stock has performed and the multiple, she would wait for a pullback such as 5%. Great long-term play.